COO vs DXCM
Cooper Companies (The) vs Dexcom — AI-powered side-by-side comparison
COO
Cooper Companies (The)
60
Buy
VS
| Metric | COO | DXCM |
|---|
| AI Score |
60
|
65
|
| Price |
$73.07
|
$89.16
|
| P/E Ratio |
64.24×
|
35.16×
|
| ROE |
4.6%
|
30.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
64.4%
|
62.5%
|
| Debt / Equity |
0.30×
|
0.53×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
54.1
|
65.4
|
| Beta |
0.823
|
1.41
|
| Expected Upside |
+0.1%
|
+2.3%
|
AI Committee View
Current Innellis committee reasoning for COO versus DXCM.
DXCM leads by 5 points.
DXCM scores 65/100 (Buy) versus COO at 60/100 (Buy).
COO Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 63.7 is expensive by classic value standards — Value
- ROE of only 2.8% -- cheap may mean cheap for a reason — Value
- EPS declining -42.6% YoY despite any revenue growth — Growth
DXCM Committee View
67% agreement
6 analysts
The primary driver is eps growing 79.4% yoy. The main limiting factor is p/e of 34.5 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 36.2% shows genuine earnings power backing the valuation — Value
- EPS growing 79.4% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- P/E of 34.5 is moderate-to-rich — Value
- Price-to-book of 9.4x prices in significant intangible value — Value
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical